- AU$7.89m
- AU$3.87m
- AU$0.18m
Australia Stock Exchange release from INVEX THERAPEUTI : Invex to Present at Bell Potter Healthcare Conference
Australia Stock Exchange release from INVEX THERAPEUTI : Notice of Webinar & Investor Presentation
Australia Stock Exchange release from INVEX THERAPEUTI : Global Phase 3 Trial of Presendin to Launch in Q4 2021
Australia Stock Exchange release from INVEX THERAPEUTI : PRE_NR Ends: 09:23:52
Australia Stock Exchange release from INVEX THERAPEUTI : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from INVEX THERAPEUTI : PRE_NR Ends: 08:46:31
Australia Stock Exchange release from INVEX THERAPEUTI : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from INVEX THERAPEUTI : Presentation at EANS 2021 Congress
Australia Stock Exchange release from INVEX THERAPEUTI : Date of AGM and Closing Date for Director Nominations
Brief: Invex Therapeutics Says Signs Long Term Collaboration And Manufacturing Agreement With Peptron, Inc.
Australia's Invex Therapeutics jumps on collaboration with S.Korea's Peptron
Australia Stock Exchange release from INVEX THERAPEUTI : Notice of Investor Call and Presentation
Australia Stock Exchange release from INVEX THERAPEUTI : PRE_NR Ends: 10:19:00
Australia Stock Exchange release from INVEX THERAPEUTI : Exclusive Collaboration and Manufacturing Agreement
Australia Stock Exchange release from INVEX THERAPEUTI : PRE_NR Ends: 10:19:00
Brief: Invex Therapeutics Seeks Trading Halt
Australia Stock Exchange release from INVEX THER : Trading Halt
Australia Stock Exchange release from INVEX THER : Corporate Governance Statement
Australia Stock Exchange release from INVEX THER : Appendix 4G